Company Filing History:
Years Active: 2002
Title: Reginald O Cann: Innovator in Selective Estrogen Receptor Modulators
Introduction
Reginald O Cann is a notable inventor based in Bear, Delaware, who has made significant contributions to the field of pharmaceuticals. His work primarily focuses on the development of selective estrogen receptor modulators, which have important implications for various health conditions.
Latest Patents
Reginald O Cann holds 1 patent for his invention titled "Specific salt forms of triphenylethylene derivatives as selective estrogen receptor modulators." This invention pertains to novel salt forms of the triphenylethylene compound, such as 3-[4(1,2-diphenyl-but-1-enyl)-phenyl]-acrylic acid. The invention provides methods for the treatment and/or prevention of breast, uterine, ovarian, prostate, and colon cancer, osteoporosis, cardiovascular disease, and benign proliferative disorders. Additionally, it includes pharmaceutical compositions of the compounds involved.
Career Highlights
Reginald O Cann is associated with Bristol-Myers Squibb Pharma Company, where he has been able to apply his innovative ideas in a collaborative environment. His work has contributed to advancements in medical treatments and therapies.
Collaborations
Throughout his career, Reginald has worked alongside talented individuals such as Gary Avonn Cain and Christopher A Teleha. These collaborations have fostered a productive atmosphere for innovation and research.
Conclusion
Reginald O Cann's contributions to the field of selective estrogen receptor modulators highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments and therapies.